Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (111-120 of 268) with videos related to

Pageof 27
Sort By:
Seminars in Cancer Biology|December 1, 1992
Tyrosine kinase inhibitorsP Workman, V G Brunton, D J Robins
Biochemical Pharmacology|December 15, 1989
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin AH M Coley, P R Twentyman, P Workman
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokineticsH F Newman, N M Bleehen, P Workman
British Journal of Cancer|February 1, 1980
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicityP Workman, N M Bleehen, C R Wiltshire
Cancer Research|May 1, 1989
Stimulation by localized tumor hyperthermia of reductive bioactivation of 2-nitroimidazole benznidazole in miceM I Walton, N M Bleehen, P Workman
Biochemical Pharmacology|October 19, 1993
The efflux of anthracyclines in multidrug-resistant cell linesH M Coley, P R Twentyman, P Workman
Radiation Research|December 1, 1980
The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazoleR A White, P Workman, J M Brown
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivoR J Maxwell, P Workman, J R Griffiths
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsM I Walton, C R Wolf, P Workman
British Journal of Cancer|May 1, 1989
Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in miceM I Walton, N M Bleehen, P Workman
Pageof 27

Showing results (111-120 of 268) with videos related to

Sort By:
Pageof 27
Seminars in Cancer Biology|December 1, 1992
Tyrosine kinase inhibitorsP Workman, V G Brunton, D J Robins
Biochemical Pharmacology|December 15, 1989
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin AH M Coley, P R Twentyman, P Workman
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokineticsH F Newman, N M Bleehen, P Workman
British Journal of Cancer|February 1, 1980
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicityP Workman, N M Bleehen, C R Wiltshire
Cancer Research|May 1, 1989
Stimulation by localized tumor hyperthermia of reductive bioactivation of 2-nitroimidazole benznidazole in miceM I Walton, N M Bleehen, P Workman
Biochemical Pharmacology|October 19, 1993
The efflux of anthracyclines in multidrug-resistant cell linesH M Coley, P R Twentyman, P Workman
Radiation Research|December 1, 1980
The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazoleR A White, P Workman, J M Brown
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivoR J Maxwell, P Workman, J R Griffiths
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxinsM I Walton, C R Wolf, P Workman
British Journal of Cancer|May 1, 1989
Effects of localised tumour hyperthermia on pimonidazole (Ro 03-8799) pharmacokinetics in miceM I Walton, N M Bleehen, P Workman
Pageof 27